171 related articles for article (PubMed ID: 33303019)
41. Paeoniflorin ameliorates murine lupus nephritis by increasing CD4
Liang CL; Lu W; Qiu F; Li D; Liu H; Zheng F; Zhang Q; Chen Y; Lu C; Li B; Dai Z
Biochem Pharmacol; 2021 Mar; 185():114434. PubMed ID: 33513343
[TBL] [Abstract][Full Text] [Related]
42. Expression and function of TNF and IL-1 receptors on human regulatory T cells.
Mercer F; Kozhaya L; Unutmaz D
PLoS One; 2010 Jan; 5(1):e8639. PubMed ID: 20066156
[TBL] [Abstract][Full Text] [Related]
43. An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering.
Inoue M; Tsuji Y; Kashiwada A; Yokoyama A; Iwata A; Abe Y; Kamada H; Tsunoda SI
Biochem Biophys Res Commun; 2024 Feb; 697():149498. PubMed ID: 38262291
[TBL] [Abstract][Full Text] [Related]
44. TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
Case K; Tran L; Yang M; Zheng H; Kuhtreiber WM; Faustman DL
J Leukoc Biol; 2020 Jun; 107(6):981-991. PubMed ID: 32449229
[TBL] [Abstract][Full Text] [Related]
45. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
[TBL] [Abstract][Full Text] [Related]
46. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells.
Inoue M; Tsuji Y; Ueno R; Miyamoto D; Tanaka K; Moriyasu Y; Shibata S; Okuda M; Ando D; Abe Y; Kamada H; Tsunoda SI
Sci Rep; 2023 Aug; 13(1):13762. PubMed ID: 37612373
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo.
Horwitz DA; Pan S; Ou JN; Wang J; Chen M; Gray JD; Zheng SG
Clin Immunol; 2013 Dec; 149(3):450-63. PubMed ID: 24211847
[TBL] [Abstract][Full Text] [Related]
48. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.
Hu Y; Xiao H; Shi T; Oppenheim JJ; Chen X
Immunology; 2014 Jun; 142(2):193-201. PubMed ID: 24383743
[TBL] [Abstract][Full Text] [Related]
49. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
Front Immunol; 2021; 12():732549. PubMed ID: 34650558
[TBL] [Abstract][Full Text] [Related]
50. Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.
Takahashi T; Tibell A; Ljung K; Saito Y; Gronlund A; Osterholm C; Holgersson J; Lundgren T; Ericzon BG; Corbascio M; Kumagai-Braesch M
Stem Cells Transl Med; 2014 Dec; 3(12):1484-94. PubMed ID: 25313200
[TBL] [Abstract][Full Text] [Related]
51. A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.
Jiang M; Liu J; Yang D; Tross D; Li P; Chen F; Alam MM; Faustman DL; Oppenheim JJ; Chen X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108345. PubMed ID: 34794079
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells augment regulatory T cell function via CD80-mediated interactions and promote allograft survival.
Mittal SK; Cho W; Elbasiony E; Guan Y; Foulsham W; Chauhan SK
Am J Transplant; 2022 Jun; 22(6):1564-1577. PubMed ID: 35170213
[TBL] [Abstract][Full Text] [Related]
53. The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response.
Moatti A; Cohen JL
Front Cell Dev Biol; 2021; 9():725473. PubMed ID: 34712661
[TBL] [Abstract][Full Text] [Related]
54. TNFα priming through its interaction with TNFR2 enhances endothelial progenitor cell immunosuppressive effect: new hope for their widespread clinical application.
Nouri Barkestani M; Shamdani S; Afshar Bakshloo M; Arouche N; Bambai B; Uzan G; Naserian S
Cell Commun Signal; 2021 Jan; 19(1):1. PubMed ID: 33397378
[TBL] [Abstract][Full Text] [Related]
55. Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis.
Chen S; Lin Z; Xi L; Zheng Y; Zhou Q; Chen X
J Leukoc Biol; 2021 Dec; 110(6):1047-1055. PubMed ID: 34494306
[TBL] [Abstract][Full Text] [Related]
56. Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.
Atretkhany KN; Mufazalov IA; Dunst J; Kuchmiy A; Gogoleva VS; Andruszewski D; Drutskaya MS; Faustman DL; Schwabenland M; Prinz M; Kruglov AA; Waisman A; Nedospasov SA
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13051-13056. PubMed ID: 30498033
[TBL] [Abstract][Full Text] [Related]
57. [Functional Study of TNFR2 Signaling and Drug Discovery Using a Protein Engineering Approach].
Tsunoda SI
Yakugaku Zasshi; 2022; 142(12):1297-1305. PubMed ID: 36450505
[TBL] [Abstract][Full Text] [Related]
58. The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population.
Svobodova E; Krulova M; Zajicova A; Pokorna K; Prochazkova J; Trosan P; Holan V
Stem Cells Dev; 2012 Apr; 21(6):901-10. PubMed ID: 21663543
[TBL] [Abstract][Full Text] [Related]
59. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
Front Immunol; 2021; 12():662048. PubMed ID: 34084166
[TBL] [Abstract][Full Text] [Related]
60. Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic Implications.
Chen X; Plebanski M
Front Immunol; 2019; 10():2126. PubMed ID: 31555303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
